GLSI Operating Cash Flow (Statement)
Greenwich Lifesciences Inc · Operating Cash Flow (Statement)
GLSI Operating Cash Flow (Statement)
Latest reported-$12.49Mperiod ending
GLSI TTM Cash from Operations (-$293.27K → -$12.49M)
TTM operating cash flow (statement)
High-resolution chart · PNG
GLSI operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -12,488,140 | |
| -12,781,497 | |
| -9,913,453 | |
| -8,591,002 | |
| -8,503,695 | |
| -7,318,432 | |
| -7,266,543 | |
| -7,568,532 | |
| -6,785,223 | |
| -6,704,360 | |
| -6,478,602 | |
| -6,494,468 | |
| -6,243,648 | |
| -5,809,372 | |
| -6,200,027 | |
| -6,294,286 | |
| -5,639,122 | |
| -5,710,740 | |
| -4,291,548 | |
| -3,180,190 | |
| -2,285,551 | |
| -1,681,232 | |
| -1,152,962 | |
| -214,167 | |
| -213,267 | |
| -213,267 | |
| -293,267 |